EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›AMST

AMST

Amesite Inc.

Next earnings Sep 28, 2026

Avoid
$1.09
▲ 0.00%
$1.09▼ -59.02%
over 1Y
L $0.79EODHDH $3.87
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W-6.0%
1M-42.6%
3M-41.1%
YTD-45.5%
1Y-59.0%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue fell -33.8% YoY.

Amesite Inc. shows $110K in FY2025 revenue (-33.8% YoY), a -3274.6% net margin, and -132.1% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$675K$697K$845K$167K$110K
Gross profit—————
Operating income—-$9.06M-$4.22M-$4.58M-$3.60M
Net income-$11.6M-$9.06M-$4.15M-$4.40M-$3.62M
Diluted EPS-$0.59-$4.67-$1.68-$1.73-$1.03
Net margin-1717.6%-1299.8%-491.5%-2638.5%-3274.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.65M
EV / EBITDA—
EV / Sales24.0
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-72.6%
FCF yield-49.3%

Quality & risk

ROIC (est.)-104.0%
Free cash flow-$2.46M
Total debt—
Net cash$2.33M
Piotroski F-Score3/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+63.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — late filing notice (2026-05-15). Worth a closer look.
  1. DEF 14A Proxy statement2026-06-03
  2. S-1/A Securities registration2026-05-26
  3. 8-K Other event2026-05-19
  4. 10-Q Quarterly report2026-05-18
  5. NT 10-Q Late filing notice2026-05-15
  6. S-1 Securities registration2026-05-12
  7. 8-K Material agreement2026-04-28
  8. 8-K Reg FD disclosure2026-04-21
  9. S-1 Securities registration2026-04-20

Recent filings

all on EDGAR ↗
DEFA14AFiling2026-06-03open ↗DEF 14APeriod ending 2026-07-132026-06-03open ↗EFFECTFiling2026-05-28open ↗S-1/AFiling2026-05-26open ↗8-KPeriod ending 2026-05-182026-05-19open ↗10-QPeriod ending 2026-03-312026-05-18open ↗4Period ending 2026-04-282026-05-18open ↗4Period ending 2026-04-282026-05-18open ↗NT 10-QPeriod ending 2026-03-312026-05-15open ↗S-1Filing2026-05-12open ↗SCHEDULE 13GFiling2026-05-01open ↗8-KPeriod ending 2026-04-272026-04-28open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthD
ProfitabilityF
Financial healthC
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
Revenue
$110K
-33.8% YoY
Net margin
-3274.6%
ROE
-132.1%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$110K-33.8%
Net income-$3.62M+17.9%
Operating income-$3.60M+21.3%
Diluted EPS-$1.03+40.5%
Cash & equivalents$2.33M+12.7%
Total assets$3.10M-6.5%
Stockholders' equity$2.74M+8.9%
Op.: -3262.4%

Frequently asked

Is Amesite Inc. (AMST) a buy?
AMST currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue fell -33.8% YoY.
What is Amesite Inc.'s quality score?
AMST scores 35.15686274509803/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001807166, latest 10-Q filed 2026-05-18) · EODHD · as of 6/22/2026, 11:29:39 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 2 open-market buys · 0 sales

2026-04-28
Sastry Ann Marie
CHIEF EXECUTIVE OFFICER
Buy174K @ $1.44$250K
2026-04-28
Parmer George
Director
Buy244K @ $1.44$350K
2026-03-07
Parmer George
Director
Exercise41.3K
2026-03-07
Brewer Barbie
Director
Exercise41.3K

Earnings history

beat/miss · move
2025-05-16—▲ +50.00%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Amesite Stock Soars 150% on New Enterprise Deal. What to Know.Bullish
finance.yahoo.com· 2026-05-20
Amesite shares skyrocket after landing largest enterprise client to date (AMST)Bullish
finance.yahoo.com· 2026-05-19
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise CustomerBullish
globenewswire.com· 2026-05-18
Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq RulesBullish
globenewswire.com· 2026-04-27
Amesite’s NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” AwardBullish
globenewswire.com· 2026-03-04
Amesite introduces AI-native EMR system, NurseMagic EMRBullish
finance.yahoo.com· 2025-12-22

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score35 vs 67
Revenue growth-33.8% vs 7.1%
Net margin-3274.6% vs 10.5%
Return on equity-132.1% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 3d
Bullish
+0.17
vs typical · 3 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.